EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update

Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider

(2021) Alessia Alunno et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

(2021) Alessia Alunno et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs

(2021) Johannes WJ Bijlsma   ANNALS OF THE RHEUMATIC DISEASES

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

(2021) Hannah Bower et al.   ANNALS OF THE RHEUMATIC DISEASES

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2021) Anja Strangfeld et al.   ANNALS OF THE RHEUMATIC DISEASES

Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al

(2021) Martin Schäfer et al.   ANNALS OF THE RHEUMATIC DISEASES

AB0222 COMPARISON OF SELF-INJECTION DEVICES FOR ADMINISTERING ANTI-TUMOR NECROSIS FACTOR AGENTS USING THE ORIGINAL QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS

(2021) Y. Hirano et al.   ANNALS OF THE RHEUMATIC DISEASES

2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19

(2021) Alessia Alunno et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider

(2021) Alessia Alunno et al.   RMD Open

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic

(2020) Ted R. Mikuls et al.   Arthritis & Rheumatology

A living WHO guideline on drugs for covid-19

(2020) François Lamontagne et al.   BMJ-British Medical Journal

Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark

(2020) René Cordtz et al.   RHEUMATOLOGY

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3

(2020) Ted R. Mikuls et al.   Arthritis & Rheumatology

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2019) Victoria Furer et al.   ANNALS OF THE RHEUMATIC DISEASES

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

(2014) Désirée van der Heijde et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

(2013) N Duru et al.   ANNALS OF THE RHEUMATIC DISEASES